Fda To Medspas: Your Lipodissolve Claims Are Misleading

By ·
Fda To Medspas: Your Lipodissolve Claims Are Misleading featured image

After countless medical professionals have expressed concern over lipodissolve and the people performing it, the FDA has decided to start cracking down on medspas that offer this unproven “fat-melting” treatment.

Lipodissolve involves injections of phosphatidylcholine and sodium dioxycholate, often with vitamins and often compounded right on the premises, that purportedly dissolve fat deposits. However, this procedure and its pharmaceutical composition has not been proven effective or safe. Regardless, it is offered by many facilities that advertise it as an alternative to liposuction, and it is often administered by staff with little to no medical training.

This week, a handful of medspas around the country offering lipodissolve received warning letters from the FDA stating, “The claims made for your lipodissolve products are false and misleading in that they are not supported by substantial evidence or substantial clinical experience.”

The FDA has yet to see credible scientific evidence of lipodissolve’s benefits, but they’ve seen plenty of complaints from consumers who were left with lumps, scars and deformities after undergoing the treatment.

In addition to citing the medspas, the FDA has also sent warnings to a Brazilian company that offers the mixtures. Almost immediately, the company put up a message on their websites stating, “Due to the current facts,” they “do not sell Lipodissolve vials anymore.”

The medspas have two weeks to stop what they’re doing and notify the FDA of their efforts to correct their violations.

Find a Doctor

Find a NewBeauty "Top Beauty Doctor" Near you

Give the Gift of Luxury

NewBeauty uses cookies for various reasons, including to analyze and improve its content and advertising. Please review our Privacy Policy and Terms of Use for more about how we use this data. By continuing to use this site, you agree to these policies.